Matthew Ronsheim - Chief of Pharma Sciences & MFG at Entasis Therapeutics Holdings Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief of Pharma Sciences & MFG
Issuer Symbol
ETTX
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Matthew Ronsheim since 13 Mar 2025

Holdings reported by Matthew Ronsheim for Entasis Therapeutics Holdings Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 0 $2.20 11 Jul 2022 Direct
Stock Option (right to buy) 0 11 Jul 2022 Direct Common Stock

Transactions reported by Matthew Ronsheim for Entasis Therapeutics Holdings Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.